Table 1.
Vasoactive Factors | |
Vasodilators | -Nitric oxide (NO) |
-Endothelium-derived hyperpolarizing factor (EDHF) | |
-Prostacyclin (PGI2) | |
Vasoconstrictors | -Endothelin 1 (ET-1) |
-Angiotensin II (Ang II) | |
-Thromboxane A2 (TXA2) | |
Growth modulators | |
Growth promoters | -Platelet-derived growth factor (PDGF) |
-Basic fibroblast growth factor (bFGF) | |
-Somatomedin-1 (IGF-1) | |
-Endothelin 1 (ET-1) | |
-Angiotensin II (Ang II) | |
-Heparan sulfate (HPS) | |
Growth inhibitors | -Transforming growth factor (TGF) |
-Nitric oxide (NO) | |
-Prostacyclin (PGI2) | |
Modulators of inflammation | |
Adhesion molecules | -Endothelial leukocyte adhesion molecule (ELAM) -Intercellular adhesion molecule (ICAM) -Vascular cell adhesion molecule (VCAM) |
Hemostatic and thrombolytic factors | |
-Tissue plasminogen activator (t-PA) -Plasminogen activator inhibitor 1 (PAI-1) -Thrombomodulin |